WELL Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
ChromaDexNASDAQ: NAGESep 2022SEC filingmedium confidence
BiotechIrvine, US
Tom Varvaro(CFO)Troy Rhonemus(COO)Reid Dabney(Director)Frank Jaksch(President and CEO)Jeff 10005 Muirlands Blvd., Suite G Baxter(Director)Steven Block(Director)
Board seatHamed Shahbazi· per SEC Form D · $3.1M raise · filed Oct 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.